Our Mendelian randomization and polygenic risks score analyses not only support this hypothesis, but also suggest that the mechanism that regulate the levels of sTREM2 levels is in fact a part of the causal pathway of AD, independently of the TREM2 risk variants. Here, TREM2 is linked to Alzheimer disease.